"Fibrosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.
Descriptor ID |
D005355
|
MeSH Number(s) |
C23.550.355
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fibrosis".
Below are MeSH descriptors whose meaning is more specific than "Fibrosis".
This graph shows the total number of publications written about "Fibrosis" by people in this website by year, and whether "Fibrosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1995 | 0 | 1 | 1 |
1996 | 0 | 1 | 1 |
1999 | 0 | 3 | 3 |
2000 | 0 | 1 | 1 |
2001 | 0 | 2 | 2 |
2002 | 0 | 1 | 1 |
2003 | 2 | 1 | 3 |
2004 | 1 | 0 | 1 |
2005 | 0 | 5 | 5 |
2006 | 0 | 2 | 2 |
2007 | 0 | 2 | 2 |
2008 | 0 | 5 | 5 |
2009 | 0 | 4 | 4 |
2010 | 0 | 5 | 5 |
2011 | 1 | 5 | 6 |
2012 | 1 | 9 | 10 |
2013 | 2 | 8 | 10 |
2014 | 1 | 6 | 7 |
2015 | 2 | 7 | 9 |
2016 | 0 | 7 | 7 |
2017 | 0 | 9 | 9 |
2018 | 2 | 5 | 7 |
2019 | 1 | 4 | 5 |
2020 | 1 | 14 | 15 |
2021 | 3 | 9 | 12 |
2022 | 0 | 10 | 10 |
2023 | 0 | 7 | 7 |
2024 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fibrosis" by people in Profiles.
-
IL11-mediated stromal cell activation may not be the master regulator of pro-fibrotic signaling downstream of TGFß. Front Immunol. 2024; 15:1293883.
-
Pictorial Review of Fibrotic Interstitial Lung Disease on High-Resolution CT Scan and Updated Classification. Chest. 2024 Apr; 165(4):908-923.
-
Implementation of a liver health check in people with type 2 diabetes. Lancet Gastroenterol Hepatol. 2024 Jan; 9(1):83-91.
-
Utility of pathologist panels for achieving consensus in NASH histologic scoring in clinical trials: Data from a phase 3 study. Hepatol Commun. 2024 Jan 01; 8(1).
-
Extracellular matrix contribution to disease progression and dysfunction in myopathy. Am J Physiol Cell Physiol. 2023 Nov 01; 325(5):C1244-C1251.
-
Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study. Hepatology. 2023 10 01; 78(4):1223-1239.
-
Liver Transplantation 2023: Status Report, Current and Future Challenges. Clin Gastroenterol Hepatol. 2023 07; 21(8):2150-2166.
-
Clinical Phenotypes of Patients With Systemic Sclerosis With Distinct Molecular Signatures in Skin. Arthritis Care Res (Hoboken). 2023 07; 75(7):1469-1480.
-
Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis. Immunol Allergy Clin North Am. 2023 05; 43(2):209-228.
-
Effects of canagliflozin on liver steatosis and fibrosis markers in patients with type 2 diabetes and chronic kidney disease: A post hoc analysis of the CREDENCE trial. Diabetes Obes Metab. 2023 05; 25(5):1413-1418.